Published: May 2022
Characterized by a rapidly growing pipeline of biosimilars and novel biologics, and the existing challenges associated with lyophilization of biotherapeutics, stakeholders are increasingly relying on service providers offering multidisciplinary expertise in this domain
Roots Analysis has announced the addition of “Lyophilization Services Market for Biopharmaceuticals (2nd Edition), 2022 – 2035” report to its list of offerings.
In order to achieve longer and commercially viable shelf lives, lyophilization has emerged as the preferred approach, enabling the manufacturing of stable and dry biopharmaceutical formulations. Presently, a number of biopharmaceutical companies are outsourcing their lyophilization operations to contract service providers that have dedicated facilities, equipment and production lines for this purpose. Further, the technological advancements in this domain have resulted in improved productivity and efficiency of the overall process.
To order this 220+ page report, which features 80+ figures and 140+ tables, please visit
More than 105 companies claim to offer lyophilization services for biopharmaceuticals, globally
Majority (48%) of the industry stakeholders are based in North America, followed by those having headquarters in Europe (42%). In addition, more than 40% of the service providers have the required capabilities to carry out the lyophilization of proteins, followed by companies offering lyophilization services for antibodies (32%) and vaccines (21%).
More than 55% of partnership agreements were inked in 2020 and 2021
Majority of the agreements related to lyophilization of biopharmaceuticals were observed to be instances of acquisitions, representing over 60% of the total partnerships. Further, most of the intercontinental, as well as intracontinental, deals have been inked by players based in North America.
Expansion activity in this domain has grown at a CAGR of ~28%, between 2018 and 2021
Around 55% of the initiatives were focused on addition of lyophilization capacity, followed by instances of facility expansions (32%) and new facility additions (14%). More than 85% of the expansions reported in this domain were local initiatives, followed by international initiatives (12%).
North America and Europe are anticipated to capture more than 70% of the market share, by 2035
In addition, the market in Asia Pacific is likely to grow at a relatively faster pace (7.8%), in the long term. Further, in 2035, majority share (52%) of the overall biopharmaceutical lyophilization market is likely to be captured by antibodies.
To request a sample copy / brochure of this report, please visit
The financial opportunity within the lyophilization services market for biopharmaceuticals has been analyzed across the following segments:
The report also features inputs from eminent industry stakeholders, according to whom, continuous growth of the biological therapeutics pipeline and increasing preference for outsourcing is likely to drive the growth of the overall lyophilization service providers market, in the coming future. The report includes detailed transcripts of discussions held with the following experts:
The research includes profiles of key players (listed below); each profile features a brief overview of the company, its financial performance (if available), recent developments and an informed future outlook.
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/lyophilization-services-market-for-biopharmaceuticals/161.html or email firstname.lastname@example.org
You may also be interested in the following titles:
1. Pharmaceutical Secondary Packaging Market: Industry Trends and Global Forecasts, 2022-2035
2. Continuous Manufacturing (Small Molecules and Biologics) Market (2nd Edition): Industry Trends and Global Forecasts, 2022-2035
3. Live Biotherapeutic Products and Microbiome Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035
4. Peptide Therapeutics: Contract API Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035
5. Biopharmaceutical Excipient Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035
6. Companion Diagnostics Development Services Market: Industry Trends and Global Forecasts, 2022-2035
+1 (415) 800 3415
+44 (122) 391 1091
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry